Skip to search.
 TSX Down 0.99% TSX Ventures Down 0.91%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
421.90 Down 7.05(1.64%) 12:37PM EST - Nasdaq Real Time Price
Add to Portfolio
Prev Close:428.95
Open:428.67
Bid:421.70 x 100
Ask:422.19 x 200
1y Target Est:444.45
Beta:0.69
Earnings Date:May 6 - May 11 (Est.)
Day's Range:421.65 - 431.69
52wk Range:269.50 - 437.64
Volume:378,849
Avg Vol (3m):841,870
Market Cap:42.98B
P/E (ttm):137.43
EPS (ttm):3.07
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
REGNDown 1.64%42.98B
AMGNDown 2.31%118.31B
NVSDown 1.37%234.09B
RHHBYUp 0.29%N/A

Key Statistics

Forward P/E (1 yr):34.24
P/S (ttm):15.50
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :10.74
Quarterly EPS Est (Mar-15) :2.70
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):2.12

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback